BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30743056)

  • 21. Unaltered Prion Pathogenesis in a Mouse Model of High-Fat Diet-Induced Insulin Resistance.
    Zhu C; Schwarz P; Abakumova I; Aguzzi A
    PLoS One; 2015; 10(12):e0144983. PubMed ID: 26658276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroinflammation in Prion Disease.
    Li B; Chen M; Zhu C
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triggering receptor expressed on myeloid cells-2 is involved in prion-induced microglial activation but does not contribute to prion pathogenesis in mouse brains.
    Zhu C; Herrmann US; Li B; Abakumova I; Moos R; Schwarz P; Rushing EJ; Colonna M; Aguzzi A
    Neurobiol Aging; 2015 May; 36(5):1994-2003. PubMed ID: 25816748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phagocytic Activities of Reactive Microglia and Astrocytes Associated with Prion Diseases Are Dysregulated in Opposite Directions.
    Sinha A; Kushwaha R; Molesworth K; Mychko O; Makarava N; Baskakov IV
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of developmental endothelial locus-1 in a subset of macrophages for engulfment of apoptotic cells.
    Hanayama R; Tanaka M; Miwa K; Nagata S
    J Immunol; 2004 Mar; 172(6):3876-82. PubMed ID: 15004195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglia Are Critical in Host Defense against Prion Disease.
    Carroll JA; Race B; Williams K; Striebel J; Chesebro B
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29769333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion infection of mouse brain reveals multiple new upregulated genes involved in neuroinflammation or signal transduction.
    Carroll JA; Striebel JF; Race B; Phillips K; Chesebro B
    J Virol; 2015 Feb; 89(4):2388-404. PubMed ID: 25505076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement facilitates early prion pathogenesis.
    Klein MA; Kaeser PS; Schwarz P; Weyd H; Xenarios I; Zinkernagel RM; Carroll MC; Verbeek JS; Botto M; Walport MJ; Molina H; Kalinke U; Acha-Orbea H; Aguzzi A
    Nat Med; 2001 Apr; 7(4):488-92. PubMed ID: 11283678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation and function of murine primary microglia in the absence of the prion protein.
    Pinheiro LP; Linden R; Mariante RM
    J Neuroimmunol; 2015 Sep; 286():25-32. PubMed ID: 26298321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of phagocytosis and lysosomal acidification suppresses neurotoxic prion peptide-induced NALP3 inflammasome activation in BV2 microglia.
    Shi F; Yang Y; Kouadir M; Fu Y; Yang L; Zhou X; Yin X; Zhao D
    J Neuroimmunol; 2013 Jul; 260(1-2):121-5. PubMed ID: 23680490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockout of fractalkine receptor Cx3cr1 does not alter disease or microglial activation in prion-infected mice.
    Striebel JF; Race B; Carroll JA; Phillips K; Chesebro B
    J Gen Virol; 2016 Jun; 97(6):1481-1487. PubMed ID: 26935332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporary upregulation of anti-inflammatory cytokine IL-13 expression in the brains of CD14 deficient mice in the early stage of prion infection.
    Hasebe R; Suzuki A; Yamasaki T; Horiuchi M
    Biochem Biophys Res Commun; 2014 Nov; 454(1):125-30. PubMed ID: 25450368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral Prion Neuroinvasion Occurs Independently of PrP
    Marshall A; Bradford BM; Clarke AR; Manson JC; Mabbott NA
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prion protein transgenes and the neuropathology in prion diseases.
    DeArmond SJ; Prusiner SB
    Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Killing of prion-damaged neurones by microglia.
    Bate C; Reid S; Williams A
    Neuroreport; 2001 Aug; 12(11):2589-94. PubMed ID: 11496154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative Impact of Complement Receptors CD21/35 (Cr2/1) on Scrapie Pathogenesis in Mice.
    Kane SJ; Swanson E; Gordon EO; Rocha S; Bender HR; Donius LR; Aguzzi A; Hannan JP; Zabel MD
    mSphere; 2017; 2(6):. PubMed ID: 29202042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incunabular immunological events in prion trafficking.
    Michel B; Meyerett-Reid C; Johnson T; Ferguson A; Wyckoff C; Pulford B; Bender H; Avery A; Telling G; Dow S; Zabel MD
    Sci Rep; 2012; 2():440. PubMed ID: 22679554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effects of Immune System Modulation on Prion Disease Susceptibility and Pathogenesis.
    Mabbott NA; Bradford BM; Pal R; Young R; Donaldson DS
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.